E-Book | March 25, 2024

Navigating Cell Therapy Process Development

Source: Cytiva

Process development (PD) involves constructing an efficient and robust process, while concurrently balancing cost considerations and overall effectiveness. Although productivity remains paramount, it is imperative to also factor in cost, revenue, material sourcing, and compliance with regulatory standards. PD is essential for cell therapy developers, enabling the establishment of a standardized process that aligns with Good Manufacturing Practice (GMP) guidelines in preparation for clinical trials and commercialization.

Taking into consideration cell therapy PD optimization prior to scaling up or out can yield substantial advantages in the pursuit of commercial success. Overlooking this crucial step risks perpetuating inefficiencies that may scale with you, presenting formidable hurdles in the future. In this eBook, we explore the main challenges and considerations inherent in cell therapy process development, equipping you with the knowledge necessary to make well-informed decisions to navigate your journey with confidence and foresight.

access the E-Book!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.

Subscribe to Biosimilar Development X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Biosimilar Development